Latest Emergency contraception Stories
PARIS and MORRISTOWN, N.J., Sept. 17 /PRNewswire-FirstCall/ -- HRA Pharma, a privately-held, European pharmaceutical company that develops healthcare solutions in reproductive health and endocrinology and makes them available worldwide, and Watson Pharmaceuticals, Inc.
The US Food and Drug Administration approved a new, longer-lasting contraceptive pill on Friday that promises to prevent pregnancy up to five days after unprotected sex.
SILVER SPRING, Md., Aug. 13 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved ella(TM) (ulipristal acetate) tablets for emergency contraception.
MORRISTOWN, N.J., Aug. 13 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), today announced that it intends to launch ellaÂ® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010.
PARIS, August 13, 2010 /PRNewswire/ -- HRA Pharma announced today that the US Food and Drug Administration (FDA) granted approval for ella(R) (ulipristal acetate) as a prescription-only emergency contraceptive indicated for use within 120 hours (five days) of unprotected intercourse or a known or suspected contraceptive failure.
Despite previous studies suggesting otherwise, a new study suggests that birth control pills work just as well to prevent pregnancy in obese women as it does in thinner women.
WASHINGTON, June 17 /PRNewswire-USNewswire/ -- The chairman of the U.S. bishops' Committee on Pro-Life Activities voiced "grave concern" to the U.S.
WASHINGTON, June 17 /PRNewswire-USNewswire/ -- This afternoon the Food and Drug Administration (FDA) Advisory Panel, considering the new "Emergency Contraceptive," Ella, which can also act as an abortifacient, voted against recommending ANY precautions or labeling that would inform women of the drug's abortifacient capabilities as well as health risks. Jeanne Monahan, Family Research Council's Director of the Center for Human Dignity, released the following statement: "The FDA is placing...
PARIS, June 17 /PRNewswire/ -- www.hra-pharma.com -HRA Pharma announced today that the U.S.
- A serpent whose bite was fabled to produce intense thirst.